1 September 2025

Last updated: Thursday 28 August 2025

Research Directory

The rise of single-arm studies in oncology

Managing the EMA Relocation

Regulatory challenges for cell therapy manufacture

EU examines incentives for the pharma industry

The risks of therapeutic genome editing

Is an EU approval better than a hospital exemption?

MedNous Briefing - The European Medicine Agency's PRIME Scheme

The Trump impact on healthcare M&A

Global oncology has many first-in-class compounds

Britain looks to life outside the EU